ALS

Stem Cells Show Protective Potential for Amyotrophic Lateral Sclerosis (ALS)

Stem cells are being increasingly used to create therapies to address diseases across a number of organs. Neurodegenerative disease is one category for which there has been an abundance of research into the potential of stem cells to slow symptom progression or reverse symptoms altogether. For some neurodegenerative diseases, such as Parkinson’s disease, the approach…

Regenerative Medicine for ALS: Results From an Early Phase Clinical Trial

ALS, which stands for amyotrophic lateral sclerosis, is a neurodegenerative disease that has no cure and no substantially effective treatment. Today, there are two drugs available that can slow the progression of ALS— riluzole and edaravone—but these agents may only be modestly effective. Sadly, patients with ALS get progressively worse, sometimes even with treatment. They…

Spinal Cord Neural Stem Cells for ALS: Results from Two Clinical Trials

Amyotrophic Lateral Sclerosis (ALS) causes muscle weakness that gets worse over time. This muscle weakness can be so disabling that patients may require devices to support movement and breathing. There are few drug treatments for ALS, if any, that make a meaningful difference in patients’ lives. Drugs such as riluzole and edavarone may slow the…

Mesenchymal Stem Cell Treatment for ALS is Safe and Feasible

Amyotrophic lateral sclerosis or ALS is a devastating, progressive neurological disease. While the precise cause is unknown, ALS does destroy nerve cells in the spinal cord, which causes several debilitating symptoms. Often the first symptom of ALS is weakness in the hands or arms that is usually more pronounced on one side of the body.…

Stem Cell Therapy and ALS: Exploring Emerging Regenerative Medicine Research
ALS Science Blog | Stemedix

Regenerative Medicine and ALS: Exploring Emerging Regenerative Medicine Research

Amyotrophic lateral sclerosis (ALS), also known as Lou Gehrig’s disease, is a progressive neurodegenerative disorder that affects nerve cells responsible for controlling voluntary muscle movement. Over time, the disease causes degeneration of motor neurons in the brain and spinal cord, leading to muscle weakness, loss of mobility, difficulty speaking and swallowing, and eventually respiratory complications.…

Regenerative Medicine for Neurodegenerative Diseases: A Promising Path Forward

Neurodegenerative diseases like Parkinson’s disease (PD), Alzheimer’s disease (AD), and amyotrophic lateral sclerosis (ALS) are among the most challenging medical conditions to treat. These disorders involve the gradual breakdown and loss of neurons in specific areas of the nervous system, leading to symptoms such as memory loss, paralysis, and impaired movement or cognition. Despite decades…

Phase II Trial Shows Promise of Repeated Stem Cell Injections for ALS Treatment

Amyotrophic Lateral Sclerosis (ALS) is a degenerative disease that affects motor neurons in the brain and spinal cord, leading to muscle paralysis and death, typically within 3-5 years of onset. Despite two FDA-approved therapies, Riluzole, and Edravarone, which offer limited benefits, there remains no cure for ALS.  Considering this, researchers have turned to Mesenchymal stem…

Everything You Need to Know About ALS

Amyotrophic lateral sclerosis (ALS) is a progressive neurodegenerative disease. Patients with this condition often experience a broad range of symptoms that get worse over time. While there’s no known cure, some interventions and regenerative therapies can be helpful.   If you or a loved one has been diagnosed with ALS, it’s important to seek as much…

The Safety and Effectiveness of Stem Cell Treatment as an Emerging Approach for ALS

Amyotrophic lateral sclerosis (ALS) is a progressive neurodegenerative disease characterized by loss of upper and lower motor neurons resulting in paralysis, respiratory insufficiency, difficulties speaking and swallowing, stiffness and spasticity, and muscle atrophy. Commonly known as Lou Gehrig’s disease, after the baseball player was diagnosed with it, ALS is diagnosed in an estimated 5,000 Americans…

Peptides with Neurotrophic Properties: Promising Therapeutics for Amyotrophic Lateral Sclerosis and Alzheimer’s Disease.

Alzheimer’s disease (AD) and amyotrophic lateral sclerosis (ALS) are two of the more common neurodegenerative diseases, with nearly seven million people in the US living with the conditions in 2023. While AD is more prevalent than ALS, they are both characterized by the progressive loss of specific neurons and glial cells in the central nervous…

Load More

Do you have questions?

We have answers. Speak with a Stemedix Care Coordinator today with no obligation. Give us a call!

Contact Us
Subscribe To Our Newsletter

Join our mailing list to receive the latest news and updates from our team.

"*" indicates required fields

This field is for validation purposes and should be left unchanged.